325 related articles for article (PubMed ID: 21034455)
1. Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus.
Yan X; Sano M; Lu L; Wang W; Zhang Q; Zhang R; Wang L; Chen Q; Fukuda K; Shen W
Cardiovasc Diabetol; 2010 Oct; 9():70. PubMed ID: 21034455
[TBL] [Abstract][Full Text] [Related]
2. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
Berezin AE; Kremzer AA
Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
[TBL] [Abstract][Full Text] [Related]
3. Serum osteopontin concentrations in relation to coronary artery disease.
Mohamadpour AH; Abdolrahmani L; Mirzaei H; Sahebkar A; Moohebati M; Ghorbani M; Ferns GA; Ghayour-Mobarhan M
Arch Med Res; 2015 Feb; 46(2):112-7. PubMed ID: 25743929
[TBL] [Abstract][Full Text] [Related]
4. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin is elevated in patients with mitral annulus calcification independent from classic cardiovascular risk factors.
Sponder M; Reuter C; Fritzer-Szekeres M; Litschauer B; Binder T; Strametz-Juranek J
BMC Cardiovasc Disord; 2016 Jun; 16():132. PubMed ID: 27283399
[TBL] [Abstract][Full Text] [Related]
6. Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.
Lu L; Pu LJ; Xu XW; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Lu AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Clin Biochem; 2007 Jul; 40(11):810-6. PubMed ID: 17499233
[TBL] [Abstract][Full Text] [Related]
7. Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study.
Eleftheriadou I; Tsilingiris D; Tentolouris A; Mourouzis I; Grigoropoulou P; Kapelios C; Pantos C; Makrilakis K; Tentolouris N
Int J Low Extrem Wounds; 2020 Jun; 19(2):180-189. PubMed ID: 32041444
[TBL] [Abstract][Full Text] [Related]
8. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.
Abdel-Azeez HA; Al-Zaky M
J Clin Lab Anal; 2010; 24(3):201-6. PubMed ID: 20486203
[TBL] [Abstract][Full Text] [Related]
9. Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus.
Barchetta I; Ceccarelli V; Cimini FA; Bertoccini L; Fraioli A; Alessandri C; Lenzi A; Baroni MG; Cavallo MG
J Endocrinol Invest; 2019 May; 42(5):513-520. PubMed ID: 30132286
[TBL] [Abstract][Full Text] [Related]
10. Soluble tumor necrosis factor receptor 1 is associated with diminished estimated glomerular filtration rate in colombian patients with type 2 diabetes.
Gómez-Banoy N; Cuevas V; Higuita A; Aranzález LH; Mockus I
J Diabetes Complications; 2016 Jul; 30(5):852-7. PubMed ID: 27068267
[TBL] [Abstract][Full Text] [Related]
11. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.
Göçer K; Aykan AÇ; Kılınç M; Göçer NS
Scand J Clin Lab Invest; 2020 Jul; 80(4):277-281. PubMed ID: 32077762
[TBL] [Abstract][Full Text] [Related]
12. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
[TBL] [Abstract][Full Text] [Related]
13. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
[TBL] [Abstract][Full Text] [Related]
14. Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency?
Zebrack JS; Anderson JL; Beddhu S; Horne BD; Bair TL; Cheung A; Muhlestein JB;
J Am Coll Cardiol; 2003 Jul; 42(1):57-63. PubMed ID: 12849660
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
Wang XB; Cui NH; Liu X; Liu X
Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
[TBL] [Abstract][Full Text] [Related]
16. Plasma nesfatin-1 and DDP-4 levels in patients with coronary artery disease: Kozani study.
Kadoglou NPE; Korakas E; Lampropoulos S; Maratou E; Kassimis G; Patsourakos N; Plotas P; Moutsatsou P; Lambadiari V
Cardiovasc Diabetol; 2021 Aug; 20(1):166. PubMed ID: 34389003
[TBL] [Abstract][Full Text] [Related]
17. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Su G; Mi S; Tao H; Li Z; Yang H; Zheng H; Zhou Y; Ma C
Cardiovasc Diabetol; 2011 Feb; 10():19. PubMed ID: 21349201
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma osteopontin levels are associated with nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wang C; He M; Peng J; Li S; Long M; Chen W; Liu D; Yang G; Zhang L
Cytokine; 2020 Jan; 125():154837. PubMed ID: 31514105
[TBL] [Abstract][Full Text] [Related]
19. Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients.
Yamaguchi H; Igarashi M; Hirata A; Tsuchiya H; Sugiyama K; Morita Y; Jimbu Y; Ohnuma H; Daimon M; Tominaga M; Kato T
Endocr J; 2004 Oct; 51(5):499-504. PubMed ID: 15516785
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis.
Shio K; Kobayashi H; Asano T; Saito R; Iwadate H; Watanabe H; Sakuma H; Segawa T; Maeda M; Ohira H
J Rheumatol; 2010 Apr; 37(4):704-10. PubMed ID: 20156944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
